Comprehensive analysis of ceRNA networks to determine genes related to prognosis, overall survival, and immune infiltration in clear cell renal carcinoma

被引:18
作者
Chalbatani, Ghanbar Mahmoodi [1 ,3 ]
Momeni, Seyed Ali [2 ]
Hadloo, Mohammad Hosein Mohammadi [1 ]
Karimi, Zhina [1 ]
Hadizadeh, Morteza [5 ]
Jalali, Seyed Amir [6 ]
Miri, Seyed Rouhollah [1 ]
Memari, Fereidoon [1 ]
Hamblin, Michael R. [4 ]
机构
[1] Univ Tehran Med Sci, Canc Res Ctr, Canc Inst Iran, Tehran, Iran
[2] Univ Tehran Med Sci, Urooncol Res Ctr, Tehran, Iran
[3] Univ Tehran Med Sci, Sch Med, Dept Med Immunol, Tehran, Iran
[4] Harvard Med Sch, Wellman Ctr Photomed, Massachusetts Gen Hosp, 40 Blossom St, Boston, MA 02114 USA
[5] Kerman Univ Med Sci, Physiol Res Ctr, Inst Basic & Clin Physiol Sci, Kerman, Iran
[6] Shahid Beheshti Univ Med Sci, Med Sch, Dept Immunol, Tehran, Iran
关键词
circRNAs; ceRNAs; Hub-genes; ccRCC; Immune infiltration; Naphazoline; Lithocholic acid; Immune gene signature; EXPRESSION; CANCER; PROLIFERATION; MICRORNAS; MIR-1238; ROLES; RNA;
D O I
10.1016/j.compbiomed.2021.105043
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Clear cell renal cell carcinoma (ccRCC) is one of the common subtypes of kidney cancer. Circular RNAs (circRNAs) act as competing endogenous RNAs (ceRNAs) to affect the expression of microRNAs (miRNAs), and hence the expression of genes involved in the development and progression of ccRCC. However, these in-teractions have not been sufficiently explored.Methods: The differential expression of circRNAs (DEC) was extracted from the GEO database, and the expression of circRNAs was analyzed by the Limma R package. The interaction of miRNAs with circRNAs was predicted using (cancer-specific circRNA database) CSCD and circinteractome database. The genes affected by the miRNAs were predicted by miRwalk version 3, and the differential expression was retrieved using TCGA. Functional enrichment was assessed and a PPI network was created using DAVID and Cytoscape, respectively. The genes with significant interactions (hub-genes) were screened, and the total survival rate of ccRCC patients was extracted from the Gene Expression Profiling Interactive Analysis (GEPIA) database. To confirm the expression of OS genes we used the Immunohistochemistry (IHC) data and TCGA database. The correlation between gene expression and immune cell infiltration was investigated using TIMER2.0. Finally, potential drug candidates were predicted by the cMAP database.Results: Four DECs (hsa_circ_0003340, hsa_circ_0007836, hsa_circ_0020303, and hsa_circ_0001873) were iden-tified, along with 11 interacting miRNAs (miR-1224-3p, miR-1294, miR-1205, miR-1231, miR-615-5p, miR-940, miR-1283, and miR-1305). These miRNAs were predicted to affect 1282 target genes, and function enrichment was used to identify the genes involved in cancer biology. 18 hub-genes (CCR1, VCAM1, NCF2, LAPTM5, NCKAP1L, CTSS, BTK, LILRB2, CD53, MPEG1, C3AR1, GPR183, C1QA, C1QC, P2RY8, LY86, CYBB, and IKZF1) were identified from a PPI network. VCAM1, NCF2, CTSS, LILRB2, MPEG1, C3AR1, P2RY8, and CYBB could affect the survival of ccRCC patients. The hub-gene expression was correlated with tumor immune cell infiltration and patient prognosis. Two potantial drug candidates, naphazoline and lithocholic acid could play a role in ccRCC therapy, as well other cancers.Conclusion: This bioinformatics analysis brings a new insight into the role of circRNA/miRNA/mRNA interactions in ccRCC pathogenesis, prognosis, and possible drug treatment or immunotherapy.
引用
收藏
页数:12
相关论文
共 47 条
  • [1] Upregulated circular RNA circ_0070934 facilitates cutaneous squamous cell carcinoma cell growth and invasion by sponging miR-1238 and miR-1247-5p
    An, Xiaoxia
    Liu, Xiguang
    Ma, Guozhang
    Li, Chen
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 513 (02) : 380 - 385
  • [2] An automated method for finding molecular complexes in large protein interaction networks
    Bader, GD
    Hogue, CW
    [J]. BMC BIOINFORMATICS, 2003, 4 (1)
  • [3] Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma
    Bi, Kevin
    He, Meng Xiao
    Bakouny, Ziad
    Kanodia, Abhay
    Napolitano, Sara
    Wu, Jingyi
    Grimaldi, Grace
    Braun, David A.
    Cuoco, Michael S.
    Mayorga, Angie
    DelloStritto, Laura
    Bouchard, Gabrielle
    Steinharter, John
    Tewari, Alok K.
    Vokes, Natalie, I
    Shannon, Erin
    Sun, Maxine
    Park, Jihye
    Chang, Steven L.
    McGregor, Bradley A.
    Haq, Rizwan
    Denize, Thomas
    Signoretti, Sabina
    Guerriero, Jennifer L.
    Vigneau, Sebastien
    Rozenblatt-Rosen, Orit
    Rotem, Asaf
    Regev, Aviv
    Choueiri, Toni K.
    Van Allen, Eliezer M.
    [J]. CANCER CELL, 2021, 39 (05) : 649 - +
  • [4] Integrative and in-vitro analysis reveal hsa_circ_001787 can act as a diagnostic biomarker for colorectal cancer
    Chalbatani, Ghanbar Mahmoodi
    Gharagouzloo, Elahe
    Memari, Fereidoon
    Dana, Hassan
    Hadloo, Mohammad Hosein Mohammadi
    Zainalinia, Neda
    Sanati, Mohammad Hossein
    Miri, Seyed Rohollah
    Mahmoodzadeh, Habibollah
    [J]. SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2021, 28 (11) : 6230 - 6238
  • [5] Regulation of glut1 mRNA by hypoxia-inducible factor-1 -: Interaction between H-ras and hypoxia
    Chen, CH
    Pore, N
    Behrooz, A
    Ismail-Beigi, F
    Maity, A
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (12) : 9519 - 9525
  • [6] MicroRNAs and complex diseases: from experimental results to computational models
    Chen, Xing
    Xie, Di
    Zhao, Qi
    You, Zhu-Hong
    [J]. BRIEFINGS IN BIOINFORMATICS, 2019, 20 (02) : 515 - 539
  • [7] Renal cancer
    Corgna, Enrichetta
    Betti, Maura
    Gatta, Gemma
    Roila, Fausto
    De Mulder, Pieter H. M.
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 64 (03) : 247 - 261
  • [8] miRWalk2.0: a comprehensive atlas of microRNA-target interactions
    Dweep, Harsh
    Gretz, Norbert
    [J]. NATURE METHODS, 2015, 12 (08) : 697 - 697
  • [9] Fischer J., 2010, Chemistry International, V32, P12, DOI DOI 10.1515/CI.2010.32.4.12
  • [10] Neutrophils as a Therapeutic Target in Cancer
    Granot, Zvi
    [J]. FRONTIERS IN IMMUNOLOGY, 2019, 10 : 1710